Omitting radiation to the lower-neck region in patients with early-stage nasopharyngeal cancer provided similar survival outcomes and reduced long-term toxicity compared to whole-neck irradiation.
Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.
The most optimal proton pump inhibitor regimen for histologic response in EoE may be a twice-daily moderate dose, with no additional benefits of a higher dose.